Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma

Hassan, Manal; Botrus, Gehan; Abdel-Wahab, Reham; Wolff, Robert; Li, Donghui; Tweardy, David; Phan, Alexandria; Hawk, Ernest; Javle, Milind; Lee, Ju-Seog; Torres, Harrys; Rashid, Asif; Lenzi, Renato; Hassabo, Hesham; Abaza, Yasmin; Shalaby, Ahmed; Lacin, ŞAHİN; Morris, Jeffrey; Patt, Yehuda; Amos, Christopher; Khaderi, Saira; Goss, John; Jalal, Prasun; Kaseb, Ahmed

doi:10.1016/j.cgh.2017.05.036

Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma

Copy For Citation

Hassan M. M., Botrus G., Abdel-Wahab R., Wolff R. A., Li D., Tweardy D., ...More

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, vol.15, no.11, pp.1791-1799, 2017 (SCI-Expanded)

Publication Type: Article / Article
Volume: 15 Issue: 11
Publication Date: 2017
Doi Number: 10.1016/j.cgh.2017.05.036
Journal Name: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1791-1799
Hacettepe University Affiliated: Yes

Abstract

BACKGROUND & AIMS: Environmental factors have been identified that affect risk of hepatocellular carcinoma (HCC), but little is known about the effects of sex hormones on liver cancer development or outcome. The authors investigated whether menopause hormone therapy (MHT) affects risk, age at onset, or outcome of HCC.